ZA983608B - Leptin as an inhibitor of tumor cell proliferation - Google Patents

Leptin as an inhibitor of tumor cell proliferation

Info

Publication number
ZA983608B
ZA983608B ZA983608A ZA983608A ZA983608B ZA 983608 B ZA983608 B ZA 983608B ZA 983608 A ZA983608 A ZA 983608A ZA 983608 A ZA983608 A ZA 983608A ZA 983608 B ZA983608 B ZA 983608B
Authority
ZA
South Africa
Prior art keywords
leptin
inhibitor
cell proliferation
tumor cell
tumor
Prior art date
Application number
ZA983608A
Other languages
English (en)
Inventor
Dalit Barkan
Batya Cohen
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA983608B publication Critical patent/ZA983608B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2264Obesity-gene products, e.g. leptin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA983608A 1997-04-29 1998-04-29 Leptin as an inhibitor of tumor cell proliferation ZA983608B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12073397A IL120733A0 (en) 1997-04-29 1997-04-29 Leptin as an inhibitor of cell proliferation

Publications (1)

Publication Number Publication Date
ZA983608B true ZA983608B (en) 1998-11-02

Family

ID=11070075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983608A ZA983608B (en) 1997-04-29 1998-04-29 Leptin as an inhibitor of tumor cell proliferation

Country Status (26)

Country Link
US (1) US7109159B1 (ja)
EP (1) EP0981365B1 (ja)
JP (1) JP4330662B2 (ja)
KR (1) KR100507731B1 (ja)
CN (1) CN1168497C (ja)
AR (1) AR012626A1 (ja)
AT (1) ATE283702T1 (ja)
AU (1) AU742927B2 (ja)
BG (1) BG63490B1 (ja)
CA (1) CA2288238A1 (ja)
CZ (1) CZ299872B6 (ja)
DE (1) DE69827942T2 (ja)
EA (1) EA002353B1 (ja)
EE (1) EE04801B1 (ja)
ES (1) ES2232944T3 (ja)
HK (1) HK1028350A1 (ja)
HU (1) HUP0002427A3 (ja)
IL (2) IL120733A0 (ja)
NO (1) NO322304B1 (ja)
NZ (1) NZ500589A (ja)
PL (1) PL195275B1 (ja)
PT (1) PT981365E (ja)
SK (1) SK284848B6 (ja)
UA (1) UA66793C2 (ja)
WO (1) WO1998048831A1 (ja)
ZA (1) ZA983608B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
IL132312A0 (en) * 1999-09-05 2001-03-19 Yeda Res & Dev Use of leptin in inhibition of endothelial cell proliferation
EP2422807A3 (en) 2004-02-11 2012-05-30 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
US7863240B2 (en) * 2004-10-08 2011-01-04 Enzo Therapeutics, Inc. Methods and uses of leptin in hepatocellular carcinoma
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
SG159551A1 (en) 2005-02-11 2010-03-30 Amylin Pharmaceuticals Inc Gip analog and hybrid polypeptides with selectable properties
AU2006279680B2 (en) 2005-08-11 2012-12-06 Amylin Pharmaceuticals, Llc Hybrid polypeptides with selectable properties
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
CN101939443B (zh) * 2008-02-08 2014-01-29 Ambrx公司 经修饰瘦素多肽和其用途
EP2326339A4 (en) * 2008-05-21 2012-06-20 Neurotez Inc METHOD FOR TREATING PROGRESSIVE COGNITIVE DISORDER IN CONNECTION WITH NEUROFIBRILLARY TANGLES
WO2010054017A1 (en) * 2008-11-04 2010-05-14 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
TWI752920B (zh) 2015-10-12 2022-01-21 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
KR102563568B1 (ko) 2016-11-08 2023-08-04 리제너론 파마슈티칼스 인코포레이티드 렙틴 수용체에 길항하는 항원-결합 단백질
MX2020006508A (es) 2017-12-18 2020-09-17 Regeneron Pharma Moleculas de union a antigeno biespecificas que se unen al receptor de leptina y/o gp130, y metodos para el uso de estas.
CA3094400A1 (en) 2018-04-06 2019-10-10 Regeneron Pharmaceuticals, Inc. A leptin receptor agonist antibody for use in treating a metabolic dysfunction or hypoleptinemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695934B2 (en) * 1995-06-30 1998-08-27 Eli Lilly And Company Methods for treating diabetes
JPH11512296A (ja) * 1995-09-19 1999-10-26 イーライ・リリー・アンド・カンパニー 医療用タンパク質をコードしているdna
CA2244693A1 (en) * 1996-01-23 1997-07-31 Progenitor, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development

Also Published As

Publication number Publication date
AR012626A1 (es) 2000-11-08
UA66793C2 (uk) 2004-06-15
IL132633A (en) 2007-07-04
EA002353B1 (ru) 2002-04-25
DE69827942T2 (de) 2005-12-08
ES2232944T3 (es) 2005-06-01
HUP0002427A2 (hu) 2000-12-28
NO995267L (no) 1999-12-28
NO995267D0 (no) 1999-10-28
CZ384899A3 (cs) 2000-06-14
NZ500589A (en) 2001-03-30
BG103832A (en) 2000-10-31
BG63490B1 (bg) 2002-03-29
CN1168497C (zh) 2004-09-29
SK284848B6 (sk) 2006-01-05
JP4330662B2 (ja) 2009-09-16
HUP0002427A3 (en) 2003-02-28
KR100507731B1 (ko) 2005-08-10
EE04801B1 (et) 2007-04-16
AU742927B2 (en) 2002-01-17
EE9900510A (et) 2000-06-15
JP2001524968A (ja) 2001-12-04
DE69827942D1 (de) 2005-01-05
AU7076298A (en) 1998-11-24
KR20010012080A (ko) 2001-02-15
IL120733A0 (en) 1997-08-14
HK1028350A1 (en) 2001-02-16
EA199900981A1 (ru) 2000-04-24
CA2288238A1 (en) 1998-11-05
WO1998048831A1 (en) 1998-11-05
ATE283702T1 (de) 2004-12-15
EP0981365B1 (en) 2004-12-01
PL195275B1 (pl) 2007-08-31
CZ299872B6 (cs) 2008-12-17
PL336582A1 (en) 2000-07-03
EP0981365A1 (en) 2000-03-01
US7109159B1 (en) 2006-09-19
SK147199A3 (en) 2000-06-12
CN1261802A (zh) 2000-08-02
PT981365E (pt) 2005-03-31
NO322304B1 (no) 2006-09-11

Similar Documents

Publication Publication Date Title
ZA983608B (en) Leptin as an inhibitor of tumor cell proliferation
EP0934404A4 (en) INHIBITION OF CELL PROLIFERATION
PL331254A1 (en) Phosphonianic inhibitors of matrix metaloproteases
EP0971723A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EG24027A (en) Pyrrolotriazine inhibitors of kinases
PL328048A1 (en) Method of obtaining compositions of ethylenic polymers
PL339738A1 (en) Novel lactamic inhibitors of metaloproteinases
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
EP1119365A4 (en) COMPOSITIONS AND METHODS FOR USING TUMOR CELLS
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
PL342964A1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
PL337331A1 (en) Cyanoguanidines as cell proliferation inhibitors
PL337091A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU9312598A (en) Inhibitors of collagen assembly
PL337031A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof
AU3459497A (en) Cancer cell proliferation inhibitors
IL132633A0 (en) Leptin as an inhibitor of tumor cell proliferation
SI0981365T1 (en) Leptin as an inhibitor of tumor cell proliferation
AU8492598A (en) Methods and compositions for tumor reduction
AU2001290241A1 (en) Tumor cell proliferation inhibitors
AU5778698A (en) Reduction of restenosis
PL336896A1 (en) Cyanoamidines as inhibitors of cell proliferation